Blarcamesine Shows Promising Results in Phase 2 Extension Study: Anavex Life Sciences

Anavex Life Sciences, OR Anavex, a leading biopharmaceutical company, has reported positive findings from the 48-week, open-label extension of their phase 2 study of blarcamesine in patients with Parkinson’s disease dementia (PDD). The investigational agent, also known as ANAVEX2-73, demonstrated favorable safety and efficacy outcomes, meeting its primary and secondary objectives in this cohort of […]

Cordelia Scaife May: Cultivating Sustainable Coexistence Through Philanthropy

 Cordelia Scaife May was a remarkable woman whose philanthropic endeavors left an indelible mark on society. Born into the prestigious Mellon family in Pittsburgh, Pennsylvania, May dedicated her life to making a difference in the world. Through strategic gifting and the establishment of foundations, she became a catalyst for change in various areas, including environmental […]